Abstract
RfaH is a transcriptional antiterminator that reduces the polarity of long operons encoding secreted and surface-associated cell components of Salmonella enterica serovar Typhimurium, including O antigen and lipopolysaccharide core sugars. A Δ rfaH mutant strain is attenuated in mice (50% lethal dose [LD 50 ], >10 8 CFU). To examine the potential for using rfaH in conjunction with other attenuating mutations, we designed a series of strains in which we replaced the native rfaH promoter with the tightly regulated arabinose-dependent araC P BAD promoter so that rfaH expression was dependent on exogenously supplied arabinose provided during in vitro growth. Following colonization of host lymphoid tissues, where arabinose was not available, the P BAD promoter was no longer active and rfaH was not expressed. In the absence of RfaH, O antigen and core sugars were not synthesized. We constructed three mutant strains that expressed different levels of RfaH by altering the ribosome-binding sequence and start codon. One mutation, ΔP rfaH178 , was introduced into the attenuated vaccine strain χ9241 (Δ pabA Δ pabB Δ asdA ) expressing the pneumococcal surface protein PspA from an Asd + balanced-lethal plasmid. Mice immunized with this strain and boosted 4 weeks later induced higher levels of serum immunoglobulin G specific for PspA and for outer membrane proteins from other enteric bacteria than either an isogenic Δ rfaH derivative or the isogenic RfaH + parent. Eight weeks after primary oral immunization, mice were challenged with 200 LD 50 of virulent S treptococcus pneumoniae WU2. Immunization with ΔP rfaH178 mutant strains led to increased levels of protection compared to that of the parent χ9241 and of a Δ rfaH derivative of χ9241.

This publication has 56 references indexed in Scilit: